How to fool a wonder drug: truncate and dimerize
- PMID: 22264784
- DOI: 10.1016/j.ccr.2011.12.017
How to fool a wonder drug: truncate and dimerize
Abstract
In a recent paper, Poulikakos et al. describe a new and potentially common mechanism whereby melanomas develop resistance to the BRAF inhibitor vemurafenib by expressing truncated forms of BRAF(V600E) that can dimerize in the absence of activated RAS. Will it be possible to block this with improved BRAF inhibitor design?
Copyright © 2012 Elsevier Inc. All rights reserved.
Comment on
-
RAF inhibitor resistance is mediated by dimerization of aberrantly spliced BRAF(V600E).Nature. 2011 Nov 23;480(7377):387-90. doi: 10.1038/nature10662. Nature. 2011. PMID: 22113612 Free PMC article.
Publication types
Grants and funding
LinkOut - more resources
Full Text Sources
Research Materials